These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


43 related items for PubMed ID: 9034745

  • 1. Intralaboratory quality assurance in cervical/vaginal cytology: evaluation of intercytologist diagnostic reproducibility.
    Cocchi V, Carretti D, Fanti S, Baldazzi P, Casotti MT, Piazzi R, Prosperi L, Morselli-Labate AM.
    Diagn Cytopathol; 1997 Jan; 16(1):87-92. PubMed ID: 9034745
    [Abstract] [Full Text] [Related]

  • 2. Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.
    Smith AE, Sherman ME, Scott DR, Tabbara SO, Dworkin L, Olson J, Thompson J, Faser C, Snell J, Schiffman M.
    Cancer; 2000 Aug 25; 90(4):201-6. PubMed ID: 10966559
    [Abstract] [Full Text] [Related]

  • 3. External quality assurance in cervical/vaginal cytology: Interlaboratory agreement in the Emilia-Romagna region of Italy.
    Cocchi V, Sintoni C, Carretti D, Sama D, Chiari U, Segala V, Delazer AL, Grilli N, Papaleo R, Ghirardini C, Bucchi L.
    Acta Cytol; 1996 Aug 25; 40(3):480-8. PubMed ID: 8669183
    [Abstract] [Full Text] [Related]

  • 4. Reclassification of negative smears as atypical squamous cells of undetermined significance in quality assurance reviews: implications and limitations.
    Stanley DE, Plowden K, Sherman ME.
    Cancer; 1999 Dec 25; 87(6):346-50. PubMed ID: 10603187
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Problems encountered with the Bethesda System: the University of Iowa experience.
    Bottles K, Reiter RC, Steiner AL, Zaleski S, Bedrossian CW, Johnson SR.
    Obstet Gynecol; 1991 Sep 25; 78(3 Pt 1):410-4. PubMed ID: 1876375
    [Abstract] [Full Text] [Related]

  • 7. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988.
    Diagn Cytopathol; 1989 Sep 25; 5(3):331-4. PubMed ID: 2791840
    [Abstract] [Full Text] [Related]

  • 8. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z, Li Y, Chen A, Song M, Zhang Y.
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec 25; 207():32-36. PubMed ID: 27816739
    [Abstract] [Full Text] [Related]

  • 9. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, Vazquez M.
    Diagn Cytopathol; 2006 Mar 25; 34(3):235-9. PubMed ID: 16470857
    [Abstract] [Full Text] [Related]

  • 10. Colposcopic findings associated with human papillomavirus infection of the vagina and the cervix.
    Paavonen J.
    Obstet Gynecol Surv; 1985 Apr 25; 40(4):185-9. PubMed ID: 2984614
    [No Abstract] [Full Text] [Related]

  • 11. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM, Kuebler DL, Wilbur DC.
    Diagn Mol Pathol; 2007 Sep 25; 16(3):125-9. PubMed ID: 17721319
    [Abstract] [Full Text] [Related]

  • 12. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
    Kurman RJ, Malkasian GD, Sedlis A, Solomon D.
    Obstet Gynecol; 1991 May 25; 77(5):779-82. PubMed ID: 1849626
    [Abstract] [Full Text] [Related]

  • 13. Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland: evaluation of treatment policy.
    Murdoch JB, Cassidy LJ, Fletcher K, Cordiner JW, Macnab JC.
    Br Med J (Clin Res Ed); 1988 Feb 06; 296(6619):381-5. PubMed ID: 2830935
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E, Bucchi L, Folicaldi S, Amadori A, Ghidoni D, Medri M, Bondi A.
    Pathologica; 1998 Apr 06; 90(2):127-32. PubMed ID: 9619055
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of the results from conventional cervico-vaginal oncotic cytology and liquid-based cytology.
    Stabile SA, Evangelista DH, Talamonte VH, Lippi UG, Lopes RG.
    Einstein (Sao Paulo); 2012 Apr 06; 10(4):466-72. PubMed ID: 23386088
    [Abstract] [Full Text] [Related]

  • 16. Intralaboratory reproducibility of cervical cytology diagnoses in the external quality assurance scheme of the Emilia-Romagna region of Italy.
    Sama D, Cotignoli T, Guerrini L, Maioli P, Sintoni C, Bucchi L.
    Gynecol Oncol; 1996 Mar 06; 60(3):404-8. PubMed ID: 8774647
    [Abstract] [Full Text] [Related]

  • 17. Morphological correlation of human papillomavirus infection of matched cervical smears and biopsies from patients with persistent mild cervical cytological abnormalities.
    Herrington CS, Evans MF, Gray W, McGee JO.
    Hum Pathol; 1995 Sep 06; 26(9):951-5. PubMed ID: 7672795
    [Abstract] [Full Text] [Related]

  • 18. Colposcopy, colpocytology and the vaginal ecosystem. Oncological, bacteriological and hormonal evaluation in a series of 400 women.
    Torrisi A, Onnis GL, Minucci D.
    Clin Exp Obstet Gynecol; 1994 Sep 06; 21(3):177-83. PubMed ID: 7923799
    [Abstract] [Full Text] [Related]

  • 19. [Preinvasive lesions in gynaecology -  vagina].
    Feranec R, Mouková L, Chovanec J.
    Klin Onkol; 2013 Sep 06; 26 Suppl():S47-8. PubMed ID: 24325164
    [Abstract] [Full Text] [Related]

  • 20. How expert are the experts? Implications for proficiency testing in cervicovaginal cytology.
    Ducatman BS, Ducatman AM.
    Arch Pathol Lab Med; 2005 May 06; 129(5):604-5. PubMed ID: 15859628
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.